In an ongoing international, multifactorial, adaptive platform, randomized, controlled trial, we evaluated simvastatin (80 mg daily) as compared with no statin (control) in critically ill patients ...

Please provide your email address to receive an email when new articles are posted on . Simvastatin plus rifaximin did not reduce progression to acute-on-chronic liver failure, complications from ...

Objective: The study compared low-density lipoprotein cholesterol (LDL-C) reduction obtained after switching patients on a statin therapy to rosuvastatin or simvastatin in real-world clinical practice ...

A popular drug used to keep cholesterol in check might be interfering with a good night's sleep, U.S. researchers said on Wednesday. A large study looking at sleep patterns of people who took the ...